Bacil Pharma Ltd.
Fundamentals
- Market cap
- ₹57.05 cr
- P/E
- 36.69×
- ROE
- 1.59%
- Debt / equity
- 0.01
- 52-week range
- 26.69 — 61.80
Bacil Pharma Ltd.
Latest quarter · Mar 2026
Strength & growth
The timeline — 10 notes on Bacil Pharma Ltd.
June 2026
- 29 Jun 26 · 11:07 AM IST Lead Lead · Micro cap
Mumbai investor Niraj Shah buys 6.44% stake in zero-revenue Bacil Pharma
Shah picks up 925,000 shares over three days as other holders reduce. The nano-cap reported zero operating revenue for FY26 but may be eyeing a fundraise.
- 25 Jun 26 · 8:33 AM IST Lead Lead · Micro cap
Bacil Pharma loses another large holder as Shah sells 2.75% stake
Manubhai Amrutlal Shah's latest sale brings his June total to over 8%, following last week's 7.10% exit by another substantial shareholder, as the nano-cap sits on zero revenue and a market cap of ₹60 crore.
- 24 Jun 26 · 10:37 AM IST Lead Lead · Micro cap
Bacil Pharma loses another big holder — Patel cuts stake by 7.10%
Nikita Hiren Patel sold nearly a third of her remaining stake, dropping from 17.17% to 10.07%. The ₹60-cr nano-cap has zero operating revenue.
- 23 Jun 26 · 5:37 PM IST Brief Brief · Micro cap
Bacil Pharma board to mull fundraising options on June 26
Nano-cap with zero operating revenue calls a board meeting to consider preferential issue, rights issue, or other modes. No concrete details yet.
- 18 Jun 26 · 3:01 PM IST Brief Brief · Micro cap
Bacil Pharma proposes R&D arm, but numbers are missing
The nano-cap with zero revenue wants a wholly-owned R&D subsidiary. No investment amount or timeline disclosed, just an intent.
- 13 Jun 26 · 12:17 PM IST Brief Brief · Micro cap
Another large Bacil Pharma shareholder sells 5.57% stake
Manubhai Amrutlal Shah reduced holding to 12.77% on June 10. It's the second substantial open-market sale in a week for the zero-revenue nano-cap.
- 11 Jun 26 · 10:31 AM IST Lead Lead · Micro cap
Nikita Patel cuts Bacil Pharma stake to 17% in open-market sale
The largest non-promoter shareholder sold 2.27% of the zero-revenue nano-cap. Bacil Pharma's market cap sits at ₹68 crore.
May 2026
- 22 May 26 · 8:50 PM IST Brief Brief · Earnings · Micro cap
Bacil Pharma remains non-operational as annual profit masks losses
The company reported zero operating revenue for FY26, relying on other income to post a bottom-line profit.
- 22 May 26 · 8:46 PM IST Brief Brief · Earnings · Micro cap
Bacil Pharma reports zero revenue for FY26
The nano-cap firm remains non-operational, relying on investment income to fund a loss of ₹61.88 lakhs.